Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Financial Report: Sanofi | Contract Pharma

What are you searching for?

Sign in
Financial News

Financial Report: Sanofi

Lantus sales slide, driving down diabetes revenues

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Sanofi
 
3Q Revenues: €9.6 billion (+3%)

3Q Earnings: €2.1 billion  (+5%)

YTD Revenues: €27.8 billion (+4%)

YTD Earnings: €5.7 billion (+4%)

Comments: Pharmaceutical sales were €7.3 billion (+3%). Diabetes sales were €1.9 billion, down 7%, as a result of lower U.S. sales of Lantus (worldwide sales -11% to €1.6 billion). Genzyme sales were €923 million in the quarter, up 33%, with strong momentum driven by Multiple Sclerosis products and Aubagio sales up 79% to €225 million. Vaccines sales were €1.7 billion, up 6%, mainly driven by Emerging Markets. Oncology sales were €376 million, up 5%. Generics sales were up 7% to €452 million. Results stated at constant exchange rates.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters